Mismatch repair deficiency, a future biomarker to guide adjuvant chemotherapy in localized small bowel adenocarcinoma?
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver（2023）
摘要
We thank Vanoli et al. for the study “Mismatch repair deficiency as prognostic factor for stage III small bowel adenocarcinoma: a multicentric international study” [ [1] DLD-23-347R1: mismatch repair deficiency as prognostic factor for stage III small bowel adenocarcinoma: a multicentric international study (in press), 2020 Google Scholar ]. Mismatch repair deficiency as prognostic factor for stage III small bowel adenocarcinoma: A multicentric international studyDigestive and Liver DiseasePreviewSmall bowel adenocarcinoma (SBA) is a rare cancer with an aggressive behavior. No study has specifically addressed the putative prognostic role of mismatch repair status in stage III SBAs. Full-Text PDF
更多查看译文
关键词
small bowel adenocarcinoma,adjuvant chemotherapy,repair deficiency,mismatch
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要